Cargando…

NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report

BACKGROUND: Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the case of NC of the nasal cavity that responded to a chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Arimizu, Kohei, Hirano, Gen, Makiyama, Chinatsu, Matsuo, Mioko, Sasaguri, Takakazu, Makiyama, Akitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245604/
https://www.ncbi.nlm.nih.gov/pubmed/30453921
http://dx.doi.org/10.1186/s12885-018-5087-x
_version_ 1783372272254320640
author Arimizu, Kohei
Hirano, Gen
Makiyama, Chinatsu
Matsuo, Mioko
Sasaguri, Takakazu
Makiyama, Akitaka
author_facet Arimizu, Kohei
Hirano, Gen
Makiyama, Chinatsu
Matsuo, Mioko
Sasaguri, Takakazu
Makiyama, Akitaka
author_sort Arimizu, Kohei
collection PubMed
description BACKGROUND: Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the case of NC of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors (ESFT). CASE PRESENTATION: A 49-year-old male presented with epistaxis and pain in the left eye. The patient had a tumor in the left nasal cavity at initial visit and it was biopsied. Firstly, the man was diagnosed with ESFT based on a histopathological examination. The tumor markedly responded to standard cytotoxic chemotherapy for ESFT with distant metastasis. After the start of therapy, a chromosomal analysis revealed an atypical translocation in ESFT and additional immunostaining was positive for anti-NUT antibody. Ultimately, the patient was definitively diagnosed with NC. He received multidisciplinary therapy and symptoms were temporarily relieved. However, he died 9 months after the diagnosis of NC. CONCLUSIONS: When a pathologically undifferentiated tumor is evident along the midline of the body, NC must be included in the differential diagnosis, and immunohistochemical staining or genetic testing/chromosomal analysis needs to be performed.
format Online
Article
Text
id pubmed-6245604
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62456042018-11-26 NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report Arimizu, Kohei Hirano, Gen Makiyama, Chinatsu Matsuo, Mioko Sasaguri, Takakazu Makiyama, Akitaka BMC Cancer Case Report BACKGROUND: Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the case of NC of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors (ESFT). CASE PRESENTATION: A 49-year-old male presented with epistaxis and pain in the left eye. The patient had a tumor in the left nasal cavity at initial visit and it was biopsied. Firstly, the man was diagnosed with ESFT based on a histopathological examination. The tumor markedly responded to standard cytotoxic chemotherapy for ESFT with distant metastasis. After the start of therapy, a chromosomal analysis revealed an atypical translocation in ESFT and additional immunostaining was positive for anti-NUT antibody. Ultimately, the patient was definitively diagnosed with NC. He received multidisciplinary therapy and symptoms were temporarily relieved. However, he died 9 months after the diagnosis of NC. CONCLUSIONS: When a pathologically undifferentiated tumor is evident along the midline of the body, NC must be included in the differential diagnosis, and immunohistochemical staining or genetic testing/chromosomal analysis needs to be performed. BioMed Central 2018-11-19 /pmc/articles/PMC6245604/ /pubmed/30453921 http://dx.doi.org/10.1186/s12885-018-5087-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Arimizu, Kohei
Hirano, Gen
Makiyama, Chinatsu
Matsuo, Mioko
Sasaguri, Takakazu
Makiyama, Akitaka
NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_full NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_fullStr NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_full_unstemmed NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_short NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_sort nut carcinoma of the nasal cavity that responded to a chemotherapy regimen for ewing’s sarcoma family of tumors: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245604/
https://www.ncbi.nlm.nih.gov/pubmed/30453921
http://dx.doi.org/10.1186/s12885-018-5087-x
work_keys_str_mv AT arimizukohei nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT hiranogen nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT makiyamachinatsu nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT matsuomioko nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT sasaguritakakazu nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT makiyamaakitaka nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport